With a robust background in life sciences and healthcare investment, the fund manager has successfully led numerous deals across North America and Europe, focusing primarily on early-stage ventures. Their strategic, operator-first approach has resulted in notable exits that underscore a commitment to building value in innovative companies. Throughout their career, they have completed over 40 investments, emphasizing a data-driven methodology to identify and support high-potential startups. The manager’s expertise spans various sectors, with a particular interest in biotechnology and digital health, positioning them as a key player in the evolving investment landscape.